ArticleAnnals of hematology2018

MYC-dependent downregulation of telomerase by FLT3 inhibitors is required for their therapeutic efficacy on acute myeloid leukemia.

Xiaolu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.